You are here: Industry Insights > NIAID

News List

Lilly Begins Clinical Testing of Therapies for COVID-19 americanpharmaceuticalreview
April 15, 2020
Eli Lilly and Company has entered into an agreement with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).
Lilly to test Olumiant, LY3127804 against COVID-19 pharmatimes
April 14, 2020
Lilly has linked with health officials in the US to assess its rheumatoid arthritis drug Olumiant (baricitinib) in patients hospitalised with COVID-19.
Lilly, NIAID to Study Baricitinib in COVID-19 contractpharma
April 14, 2020
Baricitinib's anti-inflammatory activity has been hypothesized to have a potential benefit in COVID-19.
First Patient Dosed in Moderna's COVID-19 Vaccine Trial biospace
March 17, 2020
Inside the U.S., the first clinical trial for a vaccine to the novel coronavirus that causes COVID-19 began.
Collaboration to produce new clinical stage TB drug candidates europeanpharmaceuticalreview
May 15, 2019
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded TB Alliance a CETR grant for tuberculosis drug development.
NIH scientists say advanced vaccines could limit future outbreaks europeanpharmaceuticalreview
April 28, 2019
Novel vaccine technologies are critical to improving the public health response to infectious disease threats that continually emerge and re-emerge, according to scientists at the NIAID…
NIAID plan for in-depth tuberculosis research europeanpharmaceuticalreview
April 18, 2019
NIAID has released a plan for research in the infectious disease TB in order to strengthen efforts and resolve to attack this disease…
Merck collaborates to develop vaccines against dengue biospectrumasia
December 17, 2018
Merck and Instituto Butantan have agreed to collaborate to share clinical data and other learnings from their respective dengue vaccine development programs.
NIH to support HIV care and prevention research in the US pharmaceutical-technology
December 14, 2018
The National Institute of Allergy and Infectious Diseases (NIAID), a National Institutes of Health (NIH) division, has announced plans to fund human immunodeficiency virus (HIV) care ......
IDT Biologika Awarded 10-Year NIH Contract contractpharma
October 19, 2018
Will manufacture vaccines and biologics for infectious diseases

Previous page 1 2 3 4 5 Next page